Stockreport

First Participants Vaccinated in IMUNON's IMNN-101 Phase 1 Clinical Trial [Yahoo! Finance]

Imunon, Inc.  (IMNN) 
PDF LAWRENCEVILLE, N.J., June 05, 2024 (GLOBE NEWSWIRE) -- IMUNON, Inc. (NASDAQ: IMNN ), a clinical-stage company focused on developing non-viral DNA-mediated immunotherapy [Read more]